Hiros Mustafa, Spahović Hajrudin, Selimović Mirsad, Sadović Sabina
Urology Clinic, University of Sarajevo Clinics Centre, Sarajevo, Bosnia and Herzegovina.
Bosn J Basic Med Sci. 2008 May;8(2):147-51. doi: 10.17305/bjbms.2008.2970.
The objective of this work is to verify the incidence of incidental prostate adenocarcinoma in patients who underwent radical cystoprostatectomy for invasive bladder carcinoma. We have retrospectively reviewed patients who underwent radical cystoprostatectomy for infiltrative bladder tumors in period between 2003 and 2007 year, 94 men with bladder cancer underwent radical cystoprostatectomy at Urology Clinic-University of Sarajevo Clinics Centre. Mean age of patients was 67 years, with age limits ranging between 48 and 79 years. Pathohistological evaluation was used for all specimens from RCP. We found that 9,57% of cystoprostatectomy specimens in patients with bladder cancer also contained incidental prostate cancer. This result was much lower than overall mean frequency of incidentally detected prostate cancer in other series of cystoprostatectomy cases (range, 23%-68%). In conclusion we recommended digital rectal examination (DRE) and prostate-specific antigen (PSA) test as part of the bladder cancer work up and complete removal of the prostate at cystoprostatectomy to prevent residual prostate cancer.
这项工作的目的是验证因浸润性膀胱癌接受根治性膀胱前列腺切除术的患者中偶然发现前列腺腺癌的发生率。我们回顾性分析了2003年至2007年间因浸润性膀胱肿瘤接受根治性膀胱前列腺切除术的患者,94例膀胱癌男性患者在萨拉热窝大学临床中心泌尿外科诊所接受了根治性膀胱前列腺切除术。患者的平均年龄为67岁,年龄范围在48岁至79岁之间。对所有根治性膀胱前列腺切除术标本进行了病理组织学评估。我们发现,膀胱癌患者中9.57%的膀胱前列腺切除术标本也含有偶然发现的前列腺癌。这一结果远低于其他系列膀胱前列腺切除术病例中偶然发现前列腺癌的总体平均频率(范围为23% - 68%)。总之,我们建议将直肠指检(DRE)和前列腺特异性抗原(PSA)检测作为膀胱癌检查的一部分,并在膀胱前列腺切除术中彻底切除前列腺,以预防残留前列腺癌。